newsfilter
← Latest News
GlobeNewswire·

LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections

BEVERLY, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLab® System for automated PCR-based syndromic testing in